国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

亚洲欧美日韩综合久久久久| 日韩精品一区二区三区中文| 亚洲av成人片色在线观看高潮| 中文字幕av人妻一本二本| 国产精品日日做人人爱| 好男人资源在线看免费的| 国产成人免费AV片在线观看| 丰满熟妇乱又伦精品| 精品精品国产高清a级毛片| 东南亚11孩岁女精品a片| 色窝窝免费一区二区三区| 亚洲av一区二区无码波多野结衣| 亚洲中文久久精品无码| 狼人无码精华av午夜精品| 国产精品99无码一区二区| 亚洲成AV人片在线观看无| 99久久久久99国产免费AV| 国产成人A∨激情视频厨房| 性欧美乱熟妇XXXX白浆| 欧美熟妇brazzers| 绝伦の上司に一晚人妻| 一个人看的日本hd免费| 欧美黑人乱大交BD| 性欧美videofree另类| 国产精品户外野外| 欧洲精品一卡2卡三卡4卡影视| 精品人妻无码一区二区三区性| 国产美女在线精品免费观看网址 | 人妻体验按摩调情BD| 国产猛男GAYGAYXXGV| 美女高潮黄又色高清视频免费 | 99亚洲精品自拍AV成人软件| 亚洲中文久久精品无码ww16 | 国产午夜精品无码| 久久人人爽人人爽人人片av麻烦 | 久久精品噜噜噜成人av| 五十路熟女人妻一区二区| 日韩人妻无码精品A片免费不卡| 亚洲色久国产精品久久久久影院| 精品国产乱码久久久久久免费| 11孩岁女精品A片BBB|